Pharmatelligence is not responsible for the content of external sites.
2011
The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern
Currie CJ, Johnson JA
DIABETES, OBESITY AND METABOLISM In press
Deriving health state utilities for the numerical pain rating scale
Dixon S, Poole CD, Odeyemi I, Retsa P, Chambers C, Currie CJ
HEALTH AND QUALITY OF LIFE OUTCOMES In press
Evaluation of the incremental cost to the National Health Service of prescribing analogue insulin
Holden SE, Poole CD, Morgan CLI, Currie CJ
BMJ OPEN 1:e000258 doi:10.1136/bmjopen-2011-000258
The relationship between self-reported severe pain and measures of socio-economic disadvantage
Morgan CLl, Conway P, Currie CJ
EUROPEAN JOURNAL OF PAIN In press
Clinical effectiveness of biphasic insulin aspart 30:70 versus biphasic human insulin 30 in UK general clinical practice: a retrospective database study
Morgan CLl, Evans M, Toft AD, Jenkins-Jones S, Poole CD, Currie CJ
CLINICAL THERAPEUTICS 33(1):27-35
Estimation of health-related utility (EQ-5D index) from standard clinical assessments and patient-reported outcomes of ankylosing spondylitis
Poole CD, Singh A, Koenig A, Currie CJ
RHEUMATOLOGY In press
Back to top2010
Estimation of primary care treatment costs and treatment efficacy for people with Type 1 and Type 2 diabetes in the United Kingdom from 1997 to 2007
Currie CJ, Gale EAM, Poole CD
DIABETIC MEDICINE 27(8):938-948 2010
Cancer incidence is influenced by insulin dose and metformin in type 2 diabetes
Currie CJ, Gale EA, Poole CD
VALUE IN HEALTH 13(3):A26 2010
Dispensing patterns and financial costs of glucose-lowering therapies in the UK from 2000 to 2008
Currie CJ, Peters JR, Evans M
DIABETIC MEDICINE 27(7):744-752 2010
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Currie CJ, Peters JR, Tynan A, Evans M, Heine RJ, Bracco OL, Zagar T, Poole CD
LANCET 375(9713):481-489 2010
Survival as a function of HbA1c in people with type 2 diabetes: authors' reply
Currie CJ, Poole CD
LANCET 375(9724):1434-1435 2010
Hidden costs of rotavirus disease - a retrospective matched analysis of hospital episode statistics (HES) data
Morgan C, Adlard NE, Carroll SM
VALUE IN HEALTH 13(7):A369 2010
Burden on UK secondary care of rotavirus disease and seasonal infections in children
Morgan CLl, Adlard N, Carroll S, Parvataneni L
CURRENT MEDICAL RESEARCH AND OPINION 26(10):2449-55 2010
The impact of pain on personal socio-economic disadvantage
Morgan C, Barrie J
BRITISH JOURNAL OF NEUROSCIENCE NURSING 6(4):154 2010
The impact of pain severity - as measured by the EQ-5D - on personal economic circumstances: findings from the England Health Survey
Morgan CL, Conway P, Currie CJ
ANAESTHESIA 65(10):1052 2010
The impact between pain severity as defined by the EQ-5D index on personal economic circumstances in people with arthritis, rheumatism and fibrositis: findings from the England Health Survey
Morgan CL, Conway P, Currie CJ
ANNALS OF RHEUMATIC DISEASES 69(Suppl 3):473 2010
A longitudinal study into the new and long-term use of self-monitoring blood glucose strips in the UK
Morgan CL, Griffin A, Chamberlain GH, Turkiendorf A, McEwan P, Evans LM, Owens DR
DIABETES THERAPY 1(1):1-7 2010
Castration-resistant prostate cancer (CRPC): a UK epidemiology study
Morgan C, McEwan P, Chamberlain G, Cabrera C, Parry D
VALUE IN HEALTH 13(3):A26 2010
The changing prevalence of diagnosed diabetes and its associated vascular complications in a large region of the UK
Morgan CL, Peters JR, Currie CJ
DIABETIC MEDICINE 27(6):673-678 2010
Estimated costs of acute hospital care for people with diabetes in the United Kingdom: a routine record linkage study in a large region
Morgan CLl, Peters JR, Dixon S, Currie CJ
DIABETIC MEDICINE 27(9):1066-1073 2010
Weight change for patients with type 2 diabetes: secular trends and impact of different combinations of therapy
Morgan CL, Poole CD, Jenkins-Jones S, Evans LM, Currie CJ
VALUE IN HEALTH 13(7):A286 2010
Quality of life and health-related utility analysis of adults with moderate and severe atopic dermatitis treated with tacrolimus ointment vs. topical corticosteroids
Poole CD, Chambers C, Allsopp R, Currie CJ
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 24(6):674-678 2010
A comparison of physician-rated disease severity and patient reported outcomes in mild to moderately active ulcerative colitis
Poole CD, Connolly MP, Nielsen SK, Currie CJ, Marteau P
JOURNAL OF CROHN'S AND COLITIS 4(3):275-282 2010
Variation in primary care consultation costs among non-cancer patients treated with chronic opioid analgesia in the United Kingdom
Poole CD, Conway P, Baxter G, Currie CJ
VALUE IN HEALTH 13(7):A469 2010
Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study
Poole CD, Evans LM, Peters JR, Currie CJ
VALUE IN HEALTH 13(3):A56 2010
Estimation of health care costs as a function of disease severity in people with psoriatic arthritis in the UK
Poole CD, Lebmeier M, Ara R, Rafia R, Currie CJ
RHEUMATOLOGY 49(10):1949-1956 2010
Estimating health-related utility from clinically assessed disease severity in ankylosing spondylitis
Poole CD, Singh A, Freundlich B, Koenig A, Currie CJ
VALUE IN HEALTH 13(3):A122 2010
Back to top2009
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial
Connolly MP, Nielsen SK, Currie CJ, Poole CD, Travis SPL
JOURNAL OF CROHN'S AND COLITIS 3(1):32-37 2009
An economic evaluation comparing concomitant oral and topical mesalazine versus oral mesalazine alone in mild-to-moderately active ulcerative colitis based on results from randomised controlled trial
Connolly MP, Nielsen SK, Currie CJ, Marteau P, Probert CSJ, Travis SPL
JOURNAL OF CROHN'S AND COLITIS 3(3):168-174 2009
Quality of life improvements attributed to combination therapy with oral and topical mesalazine in mild-to-moderately active ulcerative colitis
Connolly MP, Poole CD, Currie CJ, Marteau P, Nielsen SK
DIGESTION 80(4):241-246 2009
The longest ever randomised controlled trial of insulin glargine: study design and HbA1c findings
Currie CJ
DIABETOLOGIA 52(10):2234-2235 2009
The influence of glucose-lowering therapies on cancer risk in type 2 diabetes
Currie CJ, Poole CD, Gale EAM
DIABETOLOGIA 52(9):1766-1777 2009
A review of retrospective, continuous glucose monitoring: an example of a medical device where the typical primary outcome measure may be inappropriate?
Currie CJ, Poole CD, Papo NL
VALUE IN HEALTH 12(3):A109 2009
An overview and commentary on retrospective, continuous glucose monitoring for the optimisation of care for people with diabetes
Currie CJ, Poole CD, Papo NL
CURRENT MEDICAL RESEARCH AND OPINION 25(10):2389-2400 2009
Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control
Morgan CL, McEwan P, Tukiendorf A, Robinson PA, Clemens A, Plumb JM
THROMBOSIS RESEARCH 124(1):37-41 2009
What is the economic burden of disease for patients with aortic stenosis (AS) unable to undergo aortic valve replacement (AVR)?
Morgan CLl, Wendler O, Banz K, Cohen C
Annual Meeting of the Society for Cardiothoracic Surgery, Bournemouth 2009
Changes in health related utility among adults with atopic dermatitis treated with tacrolimus ointment compared to a standard corticosteroid regimen
Poole CD, Chambers C, Allsopp R, Currie CJ
VALUE IN HEALTH 12(3):A77 2009
Health-related utility among adults with atopic dermatitis treated with 0.1% tacrolimus ointment as maintenance therapy over the long term: findings from the Protopic(R) CONTROL study
Poole CD, Chambers C, Sidhu MK, Currie CJ
BRITISH JOURNAL OF DERMATOLOGY 161(6):1335-1340 2009
An evaluation of the association between C-reactive protein, the change in C-reactive protein over one year, and all-cause mortality in chronic immune-mediated inflammatory disease managed in UK general practice
Poole CD, Conway P, Currie CJ
RHEUMATOLOGY 48(1):78-82 2009
Quality of life (health-related utility) in adults with ulcerative colitis in remission vs. mild/moderate and severe relapse: findings from the Podium study
Poole CD, Nielsen SK, Currie CJ, Marteau P, Masure JA
GASTROENTEROLOGY 136(5 Suppl 1):A203 2009
Back to top2008
CHKS data should be avoided when investigating mortality
Currie CJ
RESPIRATORY MEDICINE 102(1):172 2008
Letter
Currie CJ, Evans M, Poole CD
DIABETES, OBESITY AND METABOLISM 10(1):94-95 2008
Potential flaws and biases in a randomized controlled trial (RCT) of insulin determir vs. insulin glargine by Pieber and colleagues
Alcolado J, Poole CD, Peters JR, Currie CJ
DIABETIC MEDICINE 25(1):115-116 2008
Evaluation of the association between the first observation and the longitudinal change in C-reactive protein, and all-cause mortality
Currie CJ, Poole CD, Conway P
HEART 94(4):457-462 2008
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis
Poole CD, Currie CJ, Conway P
RHEUMATOLOGY 47(Suppl 2):ii 106 2008
Mapping the dermatology quality of life index (DLQI) to health-related utility via the SF-12 in subjects with eczema
Currie CJ, Sidhu M, Poole CD
VALUE IN HEALTH 11(3):A295-A296 2008
Estimating health related utility from symptom severity in atopic dermatitis (eczema)
Poole CD, Sidhu M, Currie CJ
VALUE IN HEALTH 11(3):A296 2008
The association between C-reactive protein and the likelihood of progression to joint replacement in people with rheumatoid arthritis: a retrospective observational study
Poole CD, Conway P, Reynolds A, Currie CJ
BMC MUSCULOSKELETAL DISORDERS 9:146 2008
Once daily mesalazine for maintaining remission is cost-saving compared to twice daily mesalazine: an economic evaluation based on the PODIUM randomised controlled trial
Connolly M, Nielsen SK, Currie CJ, Poole CD
VALUE IN HEALTH 11(6):A521 2008
Quality of life (health-related utility) in adults with ulcerative colitis in remission vs. mild/moderate and severe relapse: findings from the PODIUM study
Poole CD, Nielsen SK, Currie CJ, Connolly M
VALUE IN HEALTH 11(6):A525 2008
Establishing the relationship between the ulcerative colitis disease activity instrument (UCDAI) and patient health related quality of life from a large randomised controlled trial
Poole CD, Nielsen SK, Currie CJ, Connolly M
VALUE IN HEALTH 11(6):A526 2008
The descriptive epidemiology and outcome of hospitalisations for psoriasis in the United Kingdom
Conway P, Currie CJ
VALUE IN HEALTH 11(6):A620 2008
Evaluation of treatment satisfaction with etanercept versus alternative treatments for psoriasis: a patient survey across nine European countries
Conway P, Dixon S, Currie CJ
VALUE IN HEALTH 11(6):A626 2008
Descriptive epidemiology of hospitalisation for psoriasis
Conway P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 24(12):3487-3491 2008
Back to top2007
The financial costs of healthcare treatment for people with Type 1 or Type 2 diabetes in the UK with particular reference to differing severity of peripheral neuropathy
Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR
DIABETIC MEDICINE 24(2):187-194 2007
Reliably assessing the cost-effectiveness of continuous subcutaneous insulin infusion vs. multiple daily injections in the UK: what are the issues?
Currie CJ
DIABETIC MEDICINE 24(10):1058-1059 2007
Comment and reply on: Relative efficacy/effectiveness and relative costs of treatment with insulin glargine and insulin detemir
Currie CJ, Poole CD
CURRENT MEDICAL RESEARCH AND OPINION 23(8):1762-1764 2007
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan P, Poole CD, Tetlow T, Holmes P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 23(Suppl 1):S7-S19 2007
Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 2 diabetes in the UK
McEwan P, Poole CD, Tetlow T, Holmes P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 23(Suppl 1):S21-S31 2007
The outcome of care in people with type 1 and type 2 diabetes following switching to treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Currie CJ, Poole CD, Tetlow T, Holmes P, McEwan P
CURRENT MEDICAL RESEARCH AND OPINION 23(Suppl 1):S33-S39 2007
The prescription cost of managing people with type 1 and type 2 diabetes following initiation of treatment with either insulin glargine or insulin detemir in routine general practice in the UK: a retrospective database analysis
Poole CD, Tetlow T, McEwan P, Holmes P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 23(Suppl 1):S41-S48 2007
NICE transparency - let cost effectiveness models be open to scrutiny
Poole C, Agrawal S, Currie CJ
BMJ 335:735 2007
An evaluation of glycaemic control following switching from soluble regular human insulin to either insulin lispro or other analogue insulins in people with type 1 diabetes in UK general practice
Poole CD, Currie CJ, Tynan AJ, Simpson A
DIABETOLOGIA 50(Suppl 1):S143 2007
A logistic regression model predicting those with diabetes treated with alternative short-acting insulin regimens who report hypoglycaemia to their GP
Simpson A, Poole CD, Tynan AJ, Currie CJ
DIABETOLOGIA 50(Suppl 1):S337 2007
A comparison of analogue and human short acting insulin for the treatment of type I and type 2 diabetes in UK general practice
Tynan AJ, Currie CJ, Simpson A, Poole CD
DIABETOLOGIA 50(Suppl 1):S411 2007
An economic evaluation of vasoactive agents used in the United Kingdom for acute bleeding oesophageal varices in patients with liver cirrhosis
Wechowski J, Connolly M, Woehl A, Tetlow A, McEwan P, Burroughs A, Currie CJ, Bhatt A
CURRENT MEDICAL RESEARCH AND OPINION 23(7):1481-1491 2007
Ischaemic heart disease in men
Currie CJ, Conway P, Poole CD
HEART 93(11):1471 2007
An evaluation of the association between systemic inflammation - as measured by C-reactive protein - and hospital resource use
Poole CD, Conway P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 23(11):2785-2792 2007
Evaluation of improvement in health-related quality of life using oral mesalazine alone or in combination with a mesalazine enema in active ulcerative colitis: results from a randomised controlled trial
Nielsen SK, Currie CJ, Connolly MP, Bhatt A
VALUE IN HEALTH 10(6):A230 2007
Evaluation of the association between glucose variability, as measured by the difference between maximum and minimum, intermittent, random blood glucose observations, and long term clinical outcome in subjects with type 2 diabetes treated with insulin
Poole C, Tynan A, Currie CJ
VALUE IN HEALTH 10(6):A255-A256 2007
An evaluation of treatment discontinuation patterns in people with type 1 and type 2 diabetes switched to alternative short acting insulin regimens in UK general practice
Currie CJ, Poole C, Tynan A, Simpson A
VALUE IN HEALTH 10(6):A270 2007
Evaluation of the cost-effectiveness of concomitant oral and topical mesalazine treatment versus oral treatment alone in mild-to-moderate active ulcerative colitis: a decision-analytic model
Nielsen SK, Connolly MP, Bhatt A, Currie CJ
VALUE IN HEALTH 10(6):A353 2007
The epidemiology and healthcare resource use in patients with ulcerative colitis: a population based UK study
Woehl A, Hawthorne AB, Morgan CL, Punekar Y, McEwan P
VALUE IN HEALTH 10(6):A355-A356 2007
Evaluation of the association between psoriasis severity and hospital resource use in the United Kingdom
Currie CJ, Conway P
VALUE IN HEALTH 10(6):A469 2007
Evaluation of the association between EQ5D utility and Dermatology Life Quality Index (DLQI) score in patients with psoriasis
Currie CJ, Conway P
VALUE IN HEALTH 10(6):A470-A471 2007
Back to top2006
Assessing the total costs of blood delivery to hospital oncology and haematology patients
Agrawal S, Davidson N, Walker M, Gibson S, Lim C, Morgan CL, Cowell W
CURRENT MEDICAL RESEARCH AND OPINION 22(10):1903-1909 2006
Evaluation of survival and ischaemic and thromboembolic event rates in patients with non-valvar atrial fibrillation in the general population when treated and untreated with warfarin
Currie CJ, Jones M, Goodfellow J, McEwan P, Morgan CL, Emmas C, Peters JR
HEART 92(2):196-200 2006
Comments on long-term clinical and cost outcomes of treatment with biphasic insulin aspart 30/70 versus insulin glargine in insulin-naive type 2 diabetes patients: cost-effectiveness analysis in the UK setting
Currie CJ, McEwan P, Poole C
CURRENT MEDICAL RESEARCH AND OPINION 22(5):967-968 2006
The impact of the overactive bladder on health-related utility and quality of life
Currie CJ, McEwan P, Poole CD, Odeyemi IAO, Datta SN, Morgan CL
BJU INTERNATIONAL 97(6):1267-1272 2006
Diabetes prevalence in England, 2001
Currie CJ
DIABETIC MEDICINE 23(11):1268 2006
Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetes
Currie CJ, Morgan CL, Poole CD, Sharplin P, Lammert M, McEwan P
CURRENT MEDICAL RESEARCH AND OPINION 22(8):1523-1534 2006
Randomized single versus double embryo transfer studies: obstetric and paediatric outcome and a cost-effectiveness analysis
Currie CJ, Wechowski JG
HUMAN REPRODUCTION 21(7):1939-1940 2006
The health-related utility and health-related quality of life of hospital-treated subjects with type 1 or type 2 diabetes with particular reference to differing severity of peripheral neuropathy
Currie CJ, Poole CD, Woehl A, Morgan CL, Cawley S, Rousculp MD, Covington MT, Peters JR
DIABETOLOGIA 49(10):2272-2280 2006
An evaluation of diabetes control and reports of hypoglycaemia in UK general practice following initiation of insulin glargine versus insulin detemir using observational, real-life data
Currie CJ, Tetlow AP, Holmes P, Poole CD, McEwan P
VALUE IN HEALTH 9(6):A224 2006
Should we strive for complete avoidance of blood transfusions in liver transplant recipients?
de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Woehl A, Currie CJ, Porte RJ
LIVER TRANSPLANTATION 12(5):C14 2006
Evaluation of the cost effectiveness of sirolimus versus tacrolimus for immunosuppression following renal transplantation in the UK
McEwan P, Dixon S, Baboolal K, Conway P, Currie CJ
PHARMACOECONOMICS 24(1):67-79 2006
Evaluation of the costs and outcomes from changes in risk factors in type 2 diabetes using the Cardiff stochastic simulation cost-utility model (DiabForecaster)
McEwan P, Peters JR, Bergenheim K, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 22(1):121-129 2006
External validation of the UKPDS Outcomes Model equations (UKPDS 68), and the UKPDS Risk Engine equations (UKPDS 56 and 60) in forecasting cardiovascular outcomes in people with type 2 diabetes
McEwan P, Bergenheim K, Currie CJ
VALUE IN HEALTH 9(3):A37-A38 2006
The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 1 diabetes
McEwan P, Poole CD, Holmes P, Tetlow AP, Currie CJ
VALUE IN HEALTH 9(6):A225-A226 2006
The relative cost effectiveness of insulin glargine versus NPH insulin in the UK in people with type 2 diabetes
McEwan P, Tetlow AP, Holmes P, Poole CD, Currie CJ
VALUE IN HEALTH 9(6):A227-A228 2006
Characterization and comparison of health-related utility in people with diabetes with various single and multiple vascular complications
Morgan CL, McEwan P, Morrissey M, Peters JR, Poole C, Currie CJ
DIABETIC MEDICINE 23(10):1100-1105 2006
Modelling lifetime metabolic progression and cost effectiveness of treatment strategies for type 2 diabetes
Palmer AJ, Currie CJ
PHARMACOECONOMICS 24(9):927-929 2006
An evaluation of the cost of diabetes-related medication following initiation of treatment with insulin glargine versus insulin detemir in the UK from observational, real-life data from general practice
Poole CD, Tetlow AP, Holmes P, McEwan P, Currie CJ
VALUE IN HEALTH 9(6):A224-A225 2006
The short term cost-effectiveness of 45 surgical interventions in the UK
Wechowski JG, Poole CD, Currie CJ
VALUE IN HEALTH 9(3):A173 2006
Cost-utility analysis in a UK setting of vasoactive drug treatments in acute bleeding oesophageal varices in cirrhotic patients - a discrete event simulation model
Wechowski JG, Tetlow AP, McEwan P, Woehl A, Currie CJ
VALUE IN HEALTH 9(6):A190 2006
Long term survival as a function of airway obstruction (FEV1) in subjects with chronic obstructive pulmonary disease: a population based record linkage study in a large UK population
Woehl A, Morgan CL, Currie CJ
VALUE IN HEALTH 9(3):A7 2006
The relationship between weight changes and related changes in health-related utility: evidence of cause and affect
Woehl A, Currie CJ
VALUE IN HEALTH 9(6):A326 2006
Back to top2005
Pulse pressure predicts cardiovascular risk in patients with type 2 diabetes mellitus
Cockcroft JR, Wilkinson IB, Evans M, McEwan P, Peters JR, Davies S, Scanlon MF, Currie CJ
AMERICAN JOURNAL OF HYPERTENSION 18(11):1463-1467 2005
The financial costs of hospital care for people with diabetes who have single and multiple macrovascular complications
Currie CJ, Morgan CL, Dixon S, McEwan P, Marchant N, Bearne A, Sharplin P, Peters JR
DIABETES RESEARCH AND CLINICAL PRACTICE 67(2):144-151 2005
Evaluation of the association between severity of chronic obstructive pulmonary disease (COPD) with health-related utility (EQ5Dindex) and health care resource use
Currie CJ, Griffiths T, Gosden T, Morrissey M, Patel TC, McEwan P
VALUE IN HEALTH 8(3):326 2005
The UK EQ-5Dindex: an evaluation of face validity in hospital treated subjects
Currie CJ, Mcewan P
VALUE IN HEALTH 8(3):379-380 2005
The routine collation of health outcomes data from hospital treated subjects in the Health Outcomes Data Repository (HODaR): descriptive analysis from the first 20,000 subjects
Currie CJ, McEwan P, Peters JR, Patel TC, Dixon S
VALUE IN HEALTH 8(5):581-590 2005
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
Currie CJ, McEwan P, Emmas C, Morgan CL, Peters JR
CURRENT MEDICAL RESEARCH AND OPINION 21(12):1905-1913 2005
Anticoagulation in patients with non-valvular atrial fibrillation: an evaluation of stability and early factors that predict longer-term stability on warfarin in a large UK population
Currie CJ, McEwan P, Emmas C, Peters JR
VALUE IN HEALTH 8(6):A91-A92 2005
Diabetic peripheral neuropathy: evaluation of the inter-association between the ranges of neuropathic symptoms
Currie CJ, Cawley S, Morgan CL, McEwan P, Price P, Covington M, Peters JR
VALUE IN HEALTH 8(6):A154 2005
Diabetic peripheral neuropathy: evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health care resource use and productive losses
Currie CJ, Cawley S, Morgan CL, McEwan P, Price P, Peters JR, Covington M
VALUE IN HEALTH 8(6):A167 2005
Diabetic peripheral neuropathy: evaluation of the association between neuropathic symptoms (NTSS-6-SA) and health-related utility (EQ5D)
Currie CJ, Covington M, McEwan P, Price P, Morgan CL, Cawley S, Peters JR
VALUE IN HEALTH 8(6):A172-A173 2005
Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
Davis RE, Morrissey M, Peters JR, Wittrup-Jensen K, Kennedy-Martin T, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 21(9):1477-1483 2005
The impact on health-related quality of life (EQ-5Dindex) in people with type 1 diabetes who experience severe hypoglycaemia
Davis RE, Wittrup-Jensen KU, Peters JR, Morrissey M, Currie CJ
DIABETOLOGIA 48(Suppl 1):A292-A293 804 2005
Economic analysis of the implementation of autologous transfusion technologies throughout England
Dixon S, James V, Hind D, Currie CJ
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 21(2):234-239 2005
Evaluation of the pattern of treatment, level of anticoagulation control, and outcome of treatment with warfarin in patients with non-valvar atrial fibrillation: a record linkage study in a large British population
Jones M, McEwan P, Morgan CL, Peters JR, Goodfellow J, Currie CJ
HEART 91(4):472-477 2005
Evaluation of the association between the EQ-5Dindex (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes
Lee AJ, Morgan CL, Morrissey M, Wittrup-Jensen KU, Kennedy-Martin T, Currie CJ
DIABETIC MEDICINE 22(11):1482-1486 2005
Characterisation and comparison of health-related quality of life for patients with renal failure
Lee AJ, Morgan CL, Conway P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 21(11):1777-1783 2005
Evaluation of the clinical outcome and financial costs of delaying the onset of frank type-2 diabetes
McEwan P, Peters JR, Currie CJ
VALUE IN HEALTH 8(3):355 2005
Patterns of graft and patient survival following renal transplantation and evaluation of serum creatinine as a predictor of survival: a review of data collected from one clinical centre over 34 years
McEwan P, Baboolal K, Dixon S, Conway P, Currie CJ
CURRENT MEDICAL RESEARCH AND OPINION 21(11):1793-1800 2005
Evaluation of the cost-effectiveness of sirolimus versus cyclosporin for immunosuppression after renal transplantation in the United Kingdom
McEwan P, Baboolal K, Conway P, Currie CJ
CLINICAL THERAPEUTICS 27(11):1834-1846 2005
Insulin pumps: more consultation was needed
Palmer AJ, Tucker DMD, Ray JA, Valentine WJ, Currie C, McEwan P, Brändle M
BMJ 331:905-906 2005
Evaluation of the impact on the EQ5Dindex (health-related utility) of conversion to insulin glargine (Lantus) following failure on oral agents in people with type-2 diabetes: interim analysis
Peters JR, Morrissey M, Morgan CL, Piper E, Sharplin P, Currie CJ
VALUE IN HEALTH 8(3):359 2005
The impact of the overactive bladder on quality of life (SF36) and utility (EQ5D)
Poole C, Odeyemi IA, McEwan P, Currie CJ
VALUE IN HEALTH 8(6):A85 2005
Chronic obstructive pulmonary disease: a comparison of estimates of health-related utility (EQ5D) from SF36 data alone, the SF36 plus lung function data, and the SF36 plus the St. George's Respiratory Questionnaire plus lung function data
Savani V, Currie CJ, Griffin J, Loftus J, McEwan P
VALUE IN HEALTH 8(6):A216 2005
Estimation of the financial impact of obesity on the National Health Service and society in the United Kingdom
Woehl A, Currie CJ
VALUE IN HEALTH 8(3):250 2005
Evaluation of the association between height and health-related utility (EQ5Dindex)
Woehl A, Davies S, Scanlon MF, Currie CJ
VALUE IN HEALTH 8(3):280-281 2005
Reliable measurement of obesity: risk of vascular disease complications as a function of body mass index and waist-to-hip ratio
Woehl A, Currie CJ, McEwan P, Peters JR
VALUE IN HEALTH 8(3):406-407 2005
Evaluation of the association between body mass index, waist circumference and health-related utility (EQ5D)
Woehl A, Peters JR, McEwan P, Currie CJ
VALUE IN HEALTH 8(6):A76-A77 2005
Back to top2004
Evaluation of the future supply and demand for blood products in the United Kingdom National Health Service
Currie CJ, Patel TC, McEwan P, Dixon S
TRANSFUSION MEDICINE 14(1):19-24 2004
Comparative estimates of the financial burden to the UK health system of hospital care for people with and without diabetes in the year before death
Currie CJ, Morgan CL, Dixon S, McEwan P, Marchant N, Bearne A, Sharplin P, Peters JR
DIABETES RESEARCH AND CLINICAL PRACTICE 65(3):267-274 2004
Evaluation of the association between health-related utility and obesity in hospital treated subjects
Currie CJ, Dixon S, Morrissey M, Farina C, Peters JR, McEwan P
VALUE IN HEALTH 7(3):331 2004
The impact of vascular events on health-related utility in patients with and without type-2 diabetes
Currie CJ, Peters JR, Morrissey M, Bergenheim K, McEwan P
VALUE IN HEALTH 7(6):743 2004
Evaluation of the cost utility of sirolimus versus tacrolimus for immunosuppression for renal transplantation in the United Kingdom
Currie CJ, Dixon S, Conway P, McEwan P
VALUE IN HEALTH 7(6):800 2004
Evaluation of the impact of hypoglycaemia on health care resource use, productivity, fear of hypoglycaemia and health utility in a UK population
Currie CJ, Morrissey M, Peters JR, McEwan P, Wittrup-Jensen KU, Kennedy-Martin T
DIABETOLOGIA 47(8): A323 2004
The epidemiology of hypoglycaemia in a UK population with Type 2 diabetes
Davis RE, Kennedy-Martin T, Peters JR, Wittrup-Jensen KU, McEwan P, Morrissey M, Currie CJ
DIABETOLOGIA 47(8): A84 2004
Including carer utility in economic evaluations: a preliminary analysis of the implications for funding thresholds
Dixon S, McEwan P, Currie CJ
VALUE IN HEALTH 7(3):371 2004
Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate
Evans M, McEwan P, Peters JR, Currie CJ
DIABETES OBESITY AND METABOLISM 6(4):299-307 2004
Evaluation of survival and ischaemic and thromboembolic event rates in patients with nonvalvularatrial fibrillation in the general population when treated and untreated with warfarin
Jones M, Currie CJ, McEwan P
VALUE IN HEALTH 7(6):638 2004
Using an artificial neural network to predict utility scores from SF-36 data
McEwan P, Kind P, Dixon S, Currie CJ
VALUE IN HEALTH 7(3):305 2004
Evaluating the performance of the Framingham risk equations in a population with diabetes
McEwan P, Williams JE, Griffiths JD, Bagust A, Peters JR, Hopkinson P, Currie CJ
DIABETIC MEDICINE 21(4):318-323 2004
Total cholesterol, HDL cholesterol and HbA1c affect quality-adjusted life years and hospital costs for patients with type 2 diabetes in the United Kingdom - the Cardiff Diabetes Cost Utility Model
McEwan P, Peters JR, Morrissey M, Bergenheim K, Currie CJ
VALUE IN HEALTH 7(3):341 2004
Evaluation of the cost-utility of orlistat (Xenical) in the United Kingdom
McEwan P, Jones M, Farina C, Currie CJ
VALUE IN HEALTH 7(6):721 2004
Evaluation of improved utility estimates in cost effectiveness analysis of multiple complications in type-2 diabetes
McEwan P, Peters JP, Currie CJ
VALUE IN HEALTH 7(6):735 2004
Forecasting outcomes in people with Type 2 diabetes: an evaluation of two different cardiovascular risk functions
McEwan P, Jones M, Lacey L, Bergenheim K, Currie CJ
DIABETOLOGIA 47(8): A146-A147 2004
Evaluation of the association between heath-related utility and obesity in hospital-treated subjects
McEwan P, Morrissey M, Peters JR, Dixon S, Farina C, Currie CJ
INTERNATIONAL JOURNAL OF OBESITY 28(Suppl 1):S124 2004
The outcome of initiation of antiepileptic drug monotherapy in primary care: a UK database survey
Morgan CL, Buchan S, Kerr MP
BRITISH JOURNAL OF GENERAL PRACTICE 54(507):781-783 2004
Estimated cost of inpatient admissions and outpatient appointments for a population with epilepsy: a record linkage study
Morgan CL, Kerr MP
EPILEPSIA 45(7):849-854 2004
The association between obesity (BMI) and health-related utility in subjects with Type 1 and Type 2 diabetes
Morgan CL, Peters JR, McEwan P, Currie CJ
DIABETOLOGIA 47(8): A345 2004
Back to top2003
Twelve months experience of levetiracetam (Keppra) in clinical practice: results from five centres
Beavis MJ, Morgan CLI, Grunewald R, Martland TR, Price G, Soryal I, Kerr MP
EPILEPSIA 44(Suppl s8):114 2003
The epidemiology and impact of hypoglycaemia in an Australian population: evaluation by postal survey
Connolly M, Morrissey M, Jackson L, Peters JR, Currie CJ
DIABETOLOGIA 46(Suppl 2):A434 2003
Characterisation of health utility in subjects with diabetes and self-reported diabetes-related complications
Currie C, Morrissey M, Peters J
DIABETES 52:A259 2003
Effects of insulin lispro and chronic vitamin C therapy on postprandial lipaemia, oxidative stress and endothelial function in patients with type 2 diabetes mellitus
Evans M, Anderson RA, Smith JC, Khan N, Graham JM, Thomas AW, Morris K, Deely D, Frenneaux MP, Davies JS, Rees A
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 33(3):231-238 2003
Anticoagulation with warfarin in patients with atrial fibrillation: a record linkage study of control and outcomes in a UK population
Jones M, McEwan P, Peters JR, Currie CJ
ATHEROSCLEROSIS 170(1):S5 2003
An improved model to calculate utility scores from SF-36
McEwan P, Morrissey M, Currie CJ
VALUE IN HEALTH 6(3):302-303 2003
Prevalence of epilepsy and associated health service utilization and mortality among patients with intellectual disability
Morgan CL, Baxter H, Kerr MP, MacLean WE
AMERICAN JOURNAL ON MENTAL RETARDATION 108(5):293-300 2003
Back to top2002
The influence of the Pro12Ala mutation of the PPAR-gamma receptor gene on metabolic and clinical characteristics in treatment-naive patients with type 2 diabetes
Ahluwalia M, Evans M, Morris K, Currie C, Davies S, Rees A, Thomas A
DIABETES, OBESITY AND METABOLISM 4(6):376-378 2002
The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060
Bagust A, Hopkinson PK, Maslove L, Currie CJ
DIABETIC MEDICINE 19(Suppl 4):1-5 2002
Pulse pressure predicts the risk of cardiovascular events in patients with type 2 diabetes
Cockcroft JR, Wilkinson IB, McKewan P, Evans LM, Davies JS, Peters JR, Currie CJ
JOURNAL OF HYPERTENSION 20:S176 2002
The interaction between frequency of hypoglycaemia, single and multiplevascular complications and health utility
Dixon S, Morrissey MI, Patel TC, Home PD, Peters JR, Bearne A, Sharplin P, Davies S, Currie CJ
DIABETOLOGIA 45:A101 2002
Epilepsy and mortality: a record linkage study in a UK population
Morgan CL, Kerr MP
EPILEPSIA 43(10):1251-1255 2002
Back to top2001
An economic model of the long-term health care burden of Type II diabetes
Bagust A, Hopkinson PK, Maier W, Currie CJ
DIABETOLOGIA 44(12):2140-2155 2001
Type 2 diabetes impact on quality-adjusted life expectancy
Bagust A, Hopkinson PK, Mera R, Bakst AW, Currie C
DIABETOLOGIA 44(Suppl 1):A253 1 2001
Pulse pressure predicts the risk of cardiovascular events in a large cohort of patients with type 2 diabetes
Cockcroft JR, McEwan P, Evans LM, Hopkinson P, Peters JR, Currie CJ
DIABETOLOGIA 44(Suppl 1):A46 1 2001
The relationship between cardiovascular risk and hospital bed utilisation in people with Type 2 diabetes
Currie CJ, McEwan P, Hopkinson P, Peters JR
DIABETOLOGIA 44(Suppl 1):A253 1 2001
Evaluation of a hospital diabetes specialist nursing service: a randomized controlled trial
Davies M, Dixon S, Currie CJ, Davis RE, Peters JR
DIABETIC MEDICINE 18(4):301-307 2001
The validity of the UKPDS risk equation for predicting the likelihood of cardiovascular heart disease events in Type 2 diabetes
McEwan P, Bagust A, Hopkinson P, Peters JR, Currie CJ
DIABETOLOGIA 44(Suppl 1):A253 1 2001
Estimating the prevalence of diagnosed diabetes in a health district of Wales
Morgan CL, Currie CJ, Peters JR
DIABETIC MEDICINE 18(5):423 2001
Mortality in patients with intellectual disability and epilepsy
Morgan CL, Scheepers MIA, Kerr MP
CURRENT OPINION IN PSYCHIATRY 14(5):471-475 2001
Back to top2000
The cost of diabetes: time for a different approach?
Dixon S, Currie CJ, Peters JR
DIABETIC MEDICINE 17(12):820-822 2000
Evaluating the Framingham risk equations for predicting heart disease (CHD) in type 2 diabetes
McEwan P, Currie CJ, Peters JR, Hopkinson P, Griffiths JD, Williams JE
DIABETOLOGIA 43(Suppl 2):A281 1 2000
Assessing the Framingham risk equations for predicting coronary heart disease in type 2 diabetes
McEwan PC, Peters J, Currie CJ, Hopkinson P, Griffiths JD, Williams JE
DIABETES RESEARCH AND CLINICAL PRACTICE 50(Suppl 1):195 2000
Forms of macro-vascular disease in diabetes are associated with different patterns of modifiable risk factors
McEwan PC, Peters J, Currie CJ, Hopkinson P, Griffiths JD, Williams JE
DIABETES RESEARCH AND CLINICAL PRACTICE 50(Suppl 1):345 2000
Social deprivation and prevalence of epilepsy and associated health usage
Morgan CLI, Ahmed A, Kerr MP
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 69(1):13-17 2000
Health care provision for people with a learning disability - record-linkage study of epidemiology and factors contributing to hospital care uptake
Morgan CL, Ahmed Z, Kerr MP
BRITISH JOURNAL OF PSYCHIATRY 17(1):37-41 2000
Estimating the prevalence of diagnosed diabetes in a health district of Wales: the importance of using primary and secondary care sources of ascertainment with adjustment for death and migration
Morgan CL, Currie CJ, Stott NCH, Smithers M, Butler CC, Peters JR
DIABETIC MEDICINE 17(2):141-145 2000
The prevalence of multiple diabetes-related complications
Morgan CL, Currie CJ, Stott NCH, Smithers M, Butler CC, Peters JR
DIABETIC MEDICINE 17(2):146-151 2000
Relative activity and referral patterns for diabetes and non-diabetes in general practice
Morgan CL, Currie CJ, Hunt J, Evans JD, Rogers C, Stott NCH, Peters JR
DIABETIC MEDICINE 17(3):230-235 2000
Social deprivation and prevalence of epilepsy and associated health usage - the authors reply
Morgan CL, Ahmed Z, Kerr MP
JOURNAL OF NEUROLOGY, NEUROSURGERY AND PSYCHIATRY 69(6):838 2000
Relationship between diabetes and mortality - a population study using record linkage
Morgan CL, Currie CJ, Peters JR
DIABETES CARE 23(8):1103-1107 2000
Back to top1999
Changes in glucose tolerance at high altitude
Currie CJ, Lacey LA, Peters JR
DIABETES 48(Suppl 1):A399-A400 1999
Back to top1998
The epidemiology and cost of inpatient care for peripheral vascular disease, infection, neuropathy, and ulceration in diabetes
Currie CJ, Morgan CL, Peters JR
DIABETES CARE 21(1):42-48 1998
The demand and financial cost of hospital care for diabetes mellitus and its related complications
Currie CJ, Peters JR
DIABETIC MEDICINE 15(6):449-451 1998
The demand for hospital services for patients with epilepsy
Currie CJ, Morgan CL, Peters JR, Kerr M
EPILEPSIA 39(5):537-544 1998
Regional clearing for biomedical manuscripts
Currie CJ
LANCET 351(9114):1518 1998
Evaluating CPR performance in basic life support: the VIDRAP protocol
Donnelly PD, Lester CA, Morgan CL, Assar D
RESUSCITATION 36(1):51-57 1998
Acute work injuries among electric utility meter readers
Morgan CL, Currie C, Green J, Davies S
EPIDEMIOLOGY 9(1):108 1998
Emergency care outside hospital
Morgan CL, Davies S, Green JT, Currie CJ
HOSPITAL MEDICINE 59(3):249 1998
Back to top1997
Cost effectiveness of medical ethics training
Currie C, Green J, Davies S, Morgan C
JOURNAL OF MEDICAL ETHICS 23(5):328 1997
Sex and coronary heart disease: the relative probability of dying in hospital
Currie CJ, Peters JR
HEART 77(4):371-372 1997
Estimation of unascertained diabetes prevalence: different effects on calculation of complication rates and resource utilization
Currie CJ, Peters JR
DIABETIC MEDICINE 14(6):477-481 1997
Patterns and costs of hospital care for coronary heart disease related and not related to diabetes
Currie CJ, Morgan CL, Peters JR
HEART 78(6):544-549 1997
Continuing professional development in public health medicine
Currie C, Davies S, Green J, Morgan C
JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON 31(5):582 1997
Ratio of inhaled corticosteroid to bronchodilator as indicator of quality of asthma prescribing - more adequate information systems are needed
Currie CJ, Evans M, Morgan CL
BMJ 314(7081):681 1997
NHS acute sector expenditure for diabetes: the present, future, and excess in-patient cost of care
Currie CJ, Kraus D, Morgan CL, Gill L, Stott NCH, Peters JR
DIABETIC MEDICINE 14(8):686-692 1997
Author saw fraud, misconduct, and unfairness to more junior staff
Currie C
BMJ 315(7110):747-748 1997
Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations
Currie CJ, Morgan CL, Gill L, Stott NCH, Peters JR
STROKE 28(6):1142-1146 1997
Growth hormone use by body builders
Davies JS, Morgan CLL, Currie CJ, Green JT
BRITISH JOURNAL OF SPORTS MEDICINE 31(4):352 1997
Carcinoid tumours
Davies JS, Green J, Currie C
POSTGRADUATE MEDICAL JOURNAL 73(866):836 1997
Skills of pre-registration house officers: gender differences reported in Norway
Green J, Morgan C, Currie C, Davies S
MEDICAL EDUCATION 31(5):394 1997
Koch's or Crohn's - or something else?
Green J, Davies S, Currie C, Morgan C
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE 51(7):480 1997
The course of alcohol withdrawal in a general hospital
Green J, Davies S, Morgan C, Currie C
QJM 90(8):552 1997
Risk of macrovascular complications in diabetes: comparison of the influence of gender on ischaemic heart disease and cerebrovascular disease
Hanna FWF, Currie CJ, Morgan CL, Peters JR, Rees A
ATHEROSCLEROSIS 134(1-2):309 SI 1997
Gender influence of macrovascular disease in diabetes
Hanna FWF, Currie CJ, Morgan CL, Rees A, Peters JR
Diabetologia 40(Suppl 1):A442 1997
Assessing with CARE: an innovative method of testing the approach and casualty assessment components of basic life support, using video recording
Lester CA, Morgan CL, Donnelly PD, Assar D
RESUSCITATION 34(1):43-49 1997
Hospital utilization as a function of social deprivation: diabetes vs non-diabetes
Morgan CL, Currie CJ, Peters JR
DIABETIC MEDICINE 14(7):589-594 1997
Suicides after pregnancy - mental health may deteriorate as a direct effect of induced abortion
Morgan CL, Evans M, Peters JR, Currie C
BMJ 314(7084):902 1997
Back to top1996
Patterns of in and out-patient activity for diabetes: a district survey
Currie CJ, Williams DRR, Peters JR
DIABETIC MEDICINE 13(3):273-280 1996
Costs of insulin-dependent diabetes mellitus
Currie C, Peters J
DIABETIC MEDICINE 13(7):684 1996
Gender difference in the relative risk of ischaemic heart disease in diabetes
Hanna FWF, Currie CJ, Rees A, Peters JR
DIABETOLOGIA 39(Suppl 1):A194 1996
Effectiveness of the BBC's 999 training roadshows on cardiopulmonary resuscitation: video performance of cohort of unforewarned participants at home six months afterwards
Morgan CL, Donnelly PD, Lester CA, Assar DH
BMJ 313(7062):912-916 1996